90 reports

  • 4.1 GENOMICS MARKET: OVERVIEW
  • USE OF GENOMICS IN SPECIALIZED/PERSONALIZED MEDICINE

Genomics market is projected to grow at a CAGR of 10.2% The global genomics market is estimated to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 23.88 billion in 2022 from 14.71 billion in 2017. The key factors driving the growth of the overall genomics market include the growing demand for rise in research activities...

  • Genomics
  • North America
  • Market Size
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • GLOBAL GENOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)
  • 13.4 OTHER RESEARCH TYPES

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Genomics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GERMANY: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • Collaborations/ Partnerships/ Agreements

The genome editing/genome engineering market is projected to grow at a CAGR of 14.5%. The global genome editing market is expected to grow at a CAGR of 14.5% to reach to USD 6.28 billion by 2022. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence...

  • Genomics
  • North America
  • Horizon Discovery
  • Integrated DNA Technologies, Inc.
  • Merck & Co., Inc.
  • EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2016-2023 (USD MILLION)

The gene expression market is projected to grow at a CAGR of 8.8% during the forecast period. The global gene expression market is projected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018 at a CAGR of 8.8%. Growth in the gene expression market can be attributed to factors such as the decreasing cost of sequencing,...

  • Genomics
  • North America
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • SOPHIA GENETICS ENTERS INTO AGREEMENT WITH QIAGEN
  • OMNISEQ ENTERS INTO DISTRIBUTION AGREEMENT WITH LABORATORY CORP OF AMERICA

(Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology.

  • Genomics
  • North America
  • Forecast
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • ROW: ISH MARKET SIZE, BY TECHNIQUE, 2014-2021 (USD MILLION)
  • ACADEMIC & RESEARCH INSTITUTES (6/14)

THE DIAGNOSTICS AND GENOMICS SEGMENT OF THE COMPANY OFFERS DIAGNOSTICS AND GENOMICS SOLUTIONS FOR RESEARCH AND CLINICAL LABORATORIES.

  • Genomics
  • North America
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.

REST OF WORLD PART D: ANNEXURE ##.

  • Genomics
  • Synthetic Biology
  • North America
  • United States
  • Market Shares
  • 7.2 GENOMICS
  • Genomics USD 2,153.3 Million

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves conversion of samples into a format which can be directly placed in the analytical instruments for analysis. The conversion process ranges...

  • Genomics
  • North America
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.

MARKET ##.

  • Genetic
  • Genomics
  • North America
  • United States
  • Demand

MARKET ##.

  • Genetic
  • Genomics
  • North America
  • United States
  • Demand

GENOMICS ##. ##. ##.

  • Biochip
  • Bioinformatic
  • Genomics
  • North America
  • Market Size
  • STRONG DECLINE IN THE GENOMIC TESTING COSTS, 2004-2014 (USD THOUSAND)
  • GEOGRAPHIC REVENUE MIX

The agrigenomics market is projected to grow at a CAGR of 7.8%, in terms of value The agrigenomics market is projected to reach USD 13.56 billion by 2021. Rising funds toward agrigenomics research fuel the adoption of novel technologies in crop and livestock breeding. Factors such as environmental effect of agrochemicals,...

  • Genomics
  • North America
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • STRONG DECLINE IN THE GENOMIC TESTING COSTS, 2004-2014 (USD THOUSAND)
  • GEOGRAPHIC REVENUE MIX

“The agrigenomics market is projected to grow at a CAGR of 7.8%, in terms of value” The agrigenomics market is projected to reach USD 13.56 billion by 2021. Rising funds toward agrigenomics research fuel the adoption of novel technologies in crop and livestock breeding. Factors such as environmental effect of agrochemicals, the need...

  • Genomics
  • North America
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • GENOMICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS

Growing Applications of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). A biochip is an assembly of miniaturized test sites arranged...

  • Genomics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.

Molecular Cytogenetics Market by Offering, by Technology, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2023 Chapter ##.

  • Cytogenetic
  • Genomics
  • North America
  • World
  • Market Size

One of the technological offerings under genomics is DNA sequencing.

  • Genomics
  • North America
  • Agilent Technologies, Inc.
  • Promega Corporation
  • QIAGEN N.V.

UBIQUITY GENOMICS, INC. ##. ##. ##.

  • DNA Sequencing
  • Genomics
  • North America
  • Forecast
  • Market Size
  • UNITED STATES - GENETIC TESTING MARKET (MILLION US$), 2010 - 2014

The newest developed test by Genomic Health Inc. was the Oncotype DX Genomic Prostate.

  • Genomics
  • North America
  • Cepheid
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • GENOMIC HEALTH: ANNUAL REVENUES, 2010-2016 (USD MILLION)
  • Amount Invested (USD Million)

INTRODUCTION Cancer is an extremely complex disease and medical science is still struggling to figure out the reasons and factors that influence the disease origin, propagation, spread (metastasis) and relapse. In 2017, a total of 1.7 million new cancer cases are estimated to be diagnosed in the US alone; during the same time...

  • Genomics
  • North America
  • Market Size
  • Biocept, Inc.
  • Transgenomic, Inc.

Global Military Personnel Health Monitoring Bioinformatics Market Forecast 2017-2027 ##.

  • Bioinformatic
  • Genomics
  • North America
  • World
  • Market Size
  • PRICE ANALYSIS: Rosetta Genomics Ltd. (USA)
  • Analytical Ratios: Rosetta Genomics Ltd. (USA)

A textual analysis of the financial results for Rosetta Genomics Ltd. (USA) compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Genomics
  • North America
  • United States
  • Company Financials
  • Rosetta Genomics Ltd.

EUROFINS GENOMICS ##.

  • Genomics
  • North America
  • Market Size
  • Lonza Group Ltd
  • Sanofi S.A.
  • CELL LINE CHARACTERIZATION SERVICE PROVIDERS (NON-INDUSTRY PLAYERS): DISTRIBUTION BY GEOGRAPHY AND TYPE OF CELL LINES
  • For the non-industry players marked in orange, information on the type of testing methods was unavailable

INTRODUCTION Cross contamination and cell line misidentification are some of the major concerns associated with the use of cell lines. According to published literature, cell lines used for scientific experiments are either misidentified or contaminated in approximately 15-25% cases. The use of such cell lines yields unreliable...

  • DNA
  • Genomics
  • North America
  • BioReliance Holdings, Inc.
  • Promega Corporation

(“TBUSH”) acquired Rubicon Genomics, Inc.

  • Genomics
  • North America
  • World
  • Market Size
  • Supply
  • 8.2 GENOMICS
  • GENOMICS SEGMENT WILL CONTINUE TO DOMINATE THE BIOINFORMATICS

The global bioinformatics services market projected to grow at a CAGR of 15.7%. The global bioinformatics services market is projected to reach USD 3.53 billion by 2023 from USD 1.70 million in 2018, at a CAGR of 15.7%. Factors such as increasing applications of bioinformatics in various industries, the shortage of skilled bioinformatics...

  • Bioinformatic
  • Genomics
  • North America
  • Forecast
  • Illumina, Inc.
  • NORTH AMERICA: GENOMICS MARKET SIZE, BY COUNTRY, 2016-2023 (USD MILLION)
  • EUROPE: GENOMICS MARKET SIZE, BY COUNTRY/ REGION, 2016-2023 (USD MILLION)

The global bioinformatics market is projected to grow at a CAGR of 14.5%. The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, applications of bioinformatics in proteomics and drug discovery, clinical diagnostics...

  • Genomics
  • North America
  • Forecast
  • Market Size
  • Illumina, Inc.

(U. S. ) are players that adopted this growth strategy. ## ##. ##. ## SomaLogic, Inc.

  • Genomics
  • North America
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • Vivonics, Inc.
  • GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2016-2023 (USD MILLION)
  • Takara Bio USA Holdings

The global nucleic acid isolation and purification market projected to grow at a CAGR of 9.6%. The global nucleic acid isolation and purification market is expected to reach USD 4.38 billion by 2023 from USD 2.77 billion in 2018, at a CAGR of 9.6%. Market growth is mainly driven by factors such as increasing public-private funding for...

  • Genomics
  • Nucleic Acid
  • North America
  • Forecast
  • QIAGEN N.V.
  • GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2015-2022 (USD MILLION)

The global research antibodies market (including reagents) is projected to grow at a CAGR of 6.2%. The research antibodies market (including reagents) is estimated to grow at a CAGR of 6.2% from 2017 to 2022, to reach USD 12.60 billion by 2022 from USD 9.33 billion in 2017. The increasing R&D activities and expenditure...

  • Genomics
  • North America
  • Forecast
  • Market Size
  • Merck & Co., Inc.